Development, sales and marketing of natural health products for humans and animals including vitamins, and herbal and mineral nutritional supplements.
|Head Office||Warriewood NSW|
|Registry||Computershare Investor Services|
|Chair Person||Anne Templeman-Jones|
|GICS Industry||Household & Personal Products|
|Sub Industry||Personal Products|
|Market Cap||$1,389 b|
|Shares on Issue||19 m|
|52 Week H/L|
Directors and Management
Mr Stephen Patrick Roche
Non-Executive Director 20/09/2018
Mr Roche has ASX listed experience, as both a director and as a CEO. He has experience in strategy, business development and supply chains across the pharmacy, healthcare, retail and consumer markets. Stephen has over 20 years' experience in pharmacy, manufacturing operations and supply chains, developed in roles which include his eleven-year tenure as Managing Director and CEO of Australian Pharmaceutical Industries Limited (API). Stephen is currently Managing Director of Bridgestone Australia & New Zealand. Prior to his leadership of API, Stephen held senior executive roles at Mayne and Faulding extending across health and primary care services, distribution and business development. Stephen currently serves as a Non-Executive Director of Myer Family Investments Pty Ltd, Baby Bunting Limited and Adelaide Football Club. He was previously Vice Chairman of Bridgestone China & Asia Pacific, the founding Chairman of the Priceline Sisterhood Foundation and a Non-Executive Director of Epworth Healthcare and Gold Cross Products and Services.
BBus, GAICD, FAICD Male
Ms Anne Louise Templeman-Jones
Non-Executive Chairman,Non-Executive Director 28/10/2020
Ms Templeman-Jones brings a wealth of corporate experience and is currently serving as a Non-Executive Director of Commonwealth Bank of Australia, GUD Holdings Limited and Worley Limited. During her 30 year executive career, Anne has held a number of leadership positions in corporate and private banking with domestic and offshore banks including Westpac Banking Corporation, Australia and New Zealand Banking Group Ltd, and Bank of Singapore. Anne is the former Chairperson of Commonwealth Bank's financial advice companies and has served on the boards of The Citadel Group Ltd, Cuscal Ltd, HT&E Limited, Pioneer Credit Ltd, Notre Dame University, TAL Superannuation Fund, and HBF Limited (private and general insurance companies). Anne has experience in strategy, financial and nonfinancial risk, and corporate governance. Anne is also a Director of the Cyber Security Research Centre Ltd. She is also member of Risk & Technology Committee.
BCom, EMBA, MRM, FAICD, MC(ANZ), CA Female
Ms Sharon Lee Warburton
Non-Executive Director 28/04/2021
Sharon has board and executive experience in corporate strategy, business operations, finance, accounting and risk management, along with expertise in governance and remuneration. She is currently a Non-Executive Director and Chair of the Audit and Risk Committee of Wesfarmers Limited, as well as being a Non-Executive Director of Gold Road Resources Limited and Worley Limited. Sharon has also been a part time member of the Takeovers Panel since 2015, and is an Adjunct Professor in Leadership and Strategy at Curtin University's Faculty of Business and Law. She is also member of Risk & Technology Committee.
FCA(ANZ), GAICD, FAICD, MCEW, FAIB, BBus(Acc & Bus Chartered Accountant Female
Mr David Ansell
Non-Executive Director 22/10/2013
Mr Ansell has a career in consumer-facing organisations in Australia, Asia and the United States. David played a pivotal role in the start-up years of Foxtel, was CEO of advertising agency Saatchi & Saatchi, Managing Director of Mars Incorporated in Australia, and President of a global Mars unit based in the United States. David has a operating and supply chain skill set and understanding of brand and customer strategy. David recently stepped down as Managing Director of Jacobs Douwe Egberts Peets, after six years running Australia and New Zealand's largest pure play coffee Company. Since then, he has led the acquisition of the Campos Coffee Company, which he now Chairs as an Independent Director. David is a former Director of the peak body of cycling in this country, Cycling Australia, where he served for five years until early 2020. He is also member of Risk & Technology Committee.
BA (Commu.), GAICD Male
Ms Wendy Margaret Stops
Non-Executive Director 28/04/2021
Ms Stops is Chair of the Risk & Technology Committee. She brings global information technology, operational and risk management experience with leadership roles in Asia Pacific and operational and risk management globally. Wendy is currently a Non-Executive Director with the Coles Group and Fitted for Work, a Council Member of the University of Melbourne, Chair of the Industry Advisory Board for the Melbourne Business School's Centre for Business Analytics, a member of the Digital Experts Advisory Panel for the Department of Prime Minister and Cabinet's Digital Taskforce and a member of the AICD's Governance of Technology & Innovation Panel. She was previously a Non-Executive Director of the Commonwealth Bank of Australia (2015-2020) and Altium Ltd (2018-2019).
BASci, GAICD Female
Mr Alastair Symington
Managing Director,Chief Executive Officer 16/09/2019
Mr Symington brings global FMCG experience with leadership roles in health and beauty categories across multiple geographies. Prior to joining Blackmores Alastair was the Senior Vice President of APAC, Latin America and the Middle East for Coty based in Dubai. He has experience in commercial operations across multiple geographies during his time at P&G and Coty having held roles in Market Strategy and Planning across APAC (P&G) based in Singapore, Managing Director China Wella (P&G), based in Shanghai, Head of Emerging Markets Wella) P&G, based in Geneva, and SVP Consumer Beauty, Coty based in Dubai. Alastair started his career in Australia and has a deep understanding of consumer retail and brand marketing in the local market having held roles at both at Nestle and Gillette.
BEco,PGDIB(Asian Studies),BUS, MAICD Male
Ms Erica Mann
Non-Executive Director 20/09/2021
Ms Mann has experience and understanding of complementary medicines and naturopathic principles. She has experience in over-the-counter health care products. She has worked in leadership roles in organisations at the head of health technology developments. Erica's most recent executive role was President & Head of Bayer's Global Consumer Health Division, where she directed every aspect of consumer self-care companies globally. Erica also served as Chair of the World Self-Medication Industry, a body that sets standards and guidelines for the design and labelling of non-prescription medicines and dietary supplements. Erica currently serves as a Non-Executive Director of Kellogg Company (NYSE: K), Perrigo Company PLC (NYSE: PRGO) and Supervisory Board Member at Koninklijke DSM N.V (AMS: DSM). She previously held executive positions on the boards of South African Pharmaceutical Manufacturers' Association, Medicines Australia and the International Association of Infant Food Manufacturers.
Top 20 Shareholders
|1.||HSBC Custody Nominees (Australia) Limited||3,611,759||18.65|
|2.||JP Morgan Nominees Australia Limited||2,986,113||15.42|
|3.||Mr M C Blackmore||2,197,467||11.35|
|4.||Citicorp Nominees Pty Limited||978,970||5.06|
|5.||National Nominees Limited||725,702||3.75|
|6.||Blackmore Foundation Pty Limited||696,535||3.60|
|7.||BNP Paribas Nominees Pty Ltd (DRP)||238,119||1.23|
|8.||BNP Paribas Nominees Pty Ltd (Agency Lending A/C)||225,981||1.17|
|9.||Mrs E M Whellan||150,347||0.78|
|10.||Mrs P G Wright||122,265||0.63|
|11.||Rathvale Pty Limited||113,088||0.58|
|12.||Marcus Blackmore Holdings P/L (Blackmores S/F A/C)||99,589||0.51|
|13.||Mr R Shepherd||88,179||0.46|
|14.||BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd DRP||56,219||0.29|
|15.||Netwealth Investments Limited (Wrap Services A/C)||41,974||0.22|
|16.||BNP Paribas Nominees Pty Ltd Six Sis Ltd <Drp A/C>||41,422||0.21|
|17.||Citicorp Nominees Pty Limited (Colonial First State Inv A/C)||40,071||0.21|
|18.||Powerwrap Limited (Scheme IML Trades A/C)||38,325||0.20|
|19.||Mr John Taylor||35,465||0.18|
|20.||Ms Margaret Dittman||32,191||0.17|
|10/06/2021||Anne Templeman-Jones||652||$44,922||Buy||On-market trade. Avg Price.|
|10/05/2021||Wendy Stops||2,500||$170,504||Buy||On-market trade. Avg price|
|14/12/2020||Alastair Symington||38,364||$3,165,030||Issued||Issue of securities. 73,986 - Right|